• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by QT Imaging Holdings Inc.

    2/17/26 4:13:15 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $QTI alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    QT Imaging Holdings, Inc.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    746962109

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    746962109


    1Names of Reporting Persons

    Lynrock Lake LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,154,586.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,154,586.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,154,586.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.7 %
    12Type of Reporting Person (See Instructions)

    IA, PN


    SCHEDULE 13G

    CUSIP No.
    746962109


    1Names of Reporting Persons

    LYNROCK LAKE PARTNERS LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,154,586.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,154,586.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,154,586.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.7 %
    12Type of Reporting Person (See Instructions)

    OO, HC


    SCHEDULE 13G

    CUSIP No.
    746962109


    1Names of Reporting Persons

    Paul Cynthia
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,154,586.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,154,586.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,154,586.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.7 %
    12Type of Reporting Person (See Instructions)

    IN, HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    QT Imaging Holdings, Inc.
    (b)Address of issuer's principal executive offices:

    3 Hamilton Landing, Suite 160, Novato, California, 94949
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G is being filed by (i) Lynrock Lake LP, (ii) Lynrock Lake Partners LLC, and (iii) Cynthia Paul (collectively, the "Reporting Persons").
    (b)Address or principal business office or, if none, residence:

    The principal business address of the Reporting Persons is 2 International Drive, Suite 130, Rye Brook, NY 10573.
    (c)Citizenship:

    (i) Lynrock Lake LP is a Delaware limited partnership, (ii) Lynrock Lake Partners LLC is a Delaware limited liability company, and (iii) Cynthia Paul is an individual and is a citizen of the United States.
    (d)Title of class of securities:

    Common Stock, par value $0.0001 per share
    (e)CUSIP No.:

    746962109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    Amount beneficially owned as of December 31, 2025: Lynrock Lake LP - 1,154,586 Lynrock Lake Partners LLC - 1,154,586 Cynthia Paul - 1,154,586
    (b)Percent of class:

    Percent of class as of December 31, 2025: Lynrock Lake LP - 9.7% Lynrock Lake Partners LLC - 9.7% Cynthia Paul - 9.7% Based on 11,902,198 shares of Common Stock, par value $0.0001 per share ("Common Stock"), of QT Imaging Holdings, Inc. (the "Issuer") outstanding as of December 26, 2025, as reported in the Issuer's Prospectus filed with the Securities and Exchange Commission on December 31, 2025. As of December 31, 2025, Lynrock Lake Master Fund LP ("Lynrock Lake Master") directly held 1,154,586 shares of the Issuer's Common Stock. In addition, as of December 31, 2025, Lynrock Lake Master directly held warrants of the Issuer that are not presently exercisable into shares of the Issuer's Common Stock due to certain approximately 4.9% beneficial ownership limitations. Lynrock Lake LP (the "Investment Manager") is the investment manager of Lynrock Lake Master, and pursuant to an investment management agreement, the Investment Manager has been delegated full voting and investment power over securities of the Issuer held by Lynrock Lake Master. Cynthia Paul, the Chief Investment Officer of the Investment Manager and Sole Member of Lynrock Lake Partners LLC, the general partner of the Investment Manager, may be deemed to exercise voting and investment power over securities of the Issuer held by Lynrock Lake Master
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    As of December 31, 2025, the Reporting Persons had sole power to vote or to direct the vote of 1,154,586 shares of Common Stock.

     (ii) Shared power to vote or to direct the vote:

    As of December 31, 2025, the Reporting Persons had shared power to vote or to direct the vote of 0 shares of Common Stock.

     (iii) Sole power to dispose or to direct the disposition of:

    As of December 31, 2025, the Reporting Persons had sole power to dispose or to direct the disposition of 1,154,586 shares of Common Stock.

     (iv) Shared power to dispose or to direct the disposition of:

    As of December 31, 2025, the Reporting Persons had shared power to dispose or to direct the disposition of 0 shares of Common Stock.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    As disclosed in Item 4 of this Schedule 13G, as of December 31, 2025, Lynrock Lake Master directly held 1,154,586 shares of the Issuer's Common Stock. Certain feeder funds that invest in Lynrock Lake Master may have the right to receive dividends from, or the proceeds from the sale of, the securities directly held by Lynrock Lake Master.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Lynrock Lake LP
     
    Signature:/s/ Cynthia Paul
    Name/Title:Cynthia Paul / Sole Member of Lynrock Lake Partners LLC, its general partner
    Date:02/17/2026
     
    LYNROCK LAKE PARTNERS LLC
     
    Signature:/s/ Cynthia Paul
    Name/Title:Cynthia Paul / Sole Member
    Date:02/17/2026
     
    Paul Cynthia
     
    Signature:/s/ Cynthia Paul
    Name/Title:Cynthia Paul / Self
    Date:02/17/2026
    Get the next $QTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QTI
    SEC Filings

    View All

    QT Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/18/26 8:41:05 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SCHEDULE 13G filed by QT Imaging Holdings Inc.

    SCHEDULE 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    2/17/26 4:48:41 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by QT Imaging Holdings Inc.

    SCHEDULE 13G/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    2/17/26 4:13:15 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Generated Record Revenue of $8.3 Million in Q4 2025, up 97% versus Q3 2025 Shipped Record 17 Scanners in Q4 2025 and 40 in 2025, up from 12 Scanners Shipped in 2024 Exceeded 2025 Sales Outlook, Delivering Revenue of $18.9 Million Relisted on Nasdaq Less Than One Year After Leaving the Exchange Continues to Pivot from a Scanner Company to a SaaS and Biomarker-Driven Medical Imaging Franchise QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company") a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces preliminary unaudited financial results for the fourth quarter and full year

    2/18/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Presentation at SPIE Medical Imaging 2026

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, is pleased to announce that its Chief Science Officer, Bilal Malik, Ph.D., will present at the prestigious International Society for Optics & Photonics ("SPIE") Medical Imaging meeting taking place in Vancouver, BC, Canada, from February 15–19, 2026. SPIE Medical Imaging 2026 is a premier international symposium focusing on the latest research in medical image processing, physics, and computer-aided diagnosis. The event, which is in its 50th year, covers advancements in AI, ultrasound, dig

    2/3/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QTI") a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe. The advanced machine learning algorithm enables sophisticated image interpolation, allowing the system to skip every other scan level while accurately preserving high imag

    1/14/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Leadership Updates

    Live Leadership Updates

    View All

    QT Imaging Announces First Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu

    5/10/24 8:57:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Financials

    Live finance-specific insights

    View All

    QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Generated Record Revenue of $8.3 Million in Q4 2025, up 97% versus Q3 2025 Shipped Record 17 Scanners in Q4 2025 and 40 in 2025, up from 12 Scanners Shipped in 2024 Exceeded 2025 Sales Outlook, Delivering Revenue of $18.9 Million Relisted on Nasdaq Less Than One Year After Leaving the Exchange Continues to Pivot from a Scanner Company to a SaaS and Biomarker-Driven Medical Imaging Franchise QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company") a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces preliminary unaudited financial results for the fourth quarter and full year

    2/18/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Third Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results

    11/13/24 8:32:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Second Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp

    8/8/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/22/24 4:15:11 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    9/13/24 4:23:43 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care